NASDAQ · PHARMACEUTICAL PREPARATIONS · LARGE CAP
Legend Biotech Corp. LEGN
8 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 1.0B
Revenue, FY2025 · full 8-year series below
Revenue $B
Net income $B
FY2025 · Revenue 1.0 · Net income -0.3
Compound annual growth
Revenue compounded at +68.8% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−29 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -13.3% · Net -28.8%
ROE
FY2025 · ROE -28.5%
Each USD of equity lost 29 cents this year.
The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue $B | 1.0 | 0.6 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Operating income $B | −0.1 | −0.3 | −0.5 | · | · | · | · | · |
| EBITDA $B | · | · | · | · | · | · | · | · |
| Income tax $B | 0.0 | 0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 |
| Net income $B | −0.3 | −0.2 | −0.5 | −0.4 | −0.4 | −0.3 | −0.1 | −0.0 |
| Free cash flow $B | −0.1 | −0.2 | −0.4 | −0.2 | −0.2 | −0.2 | −0.1 | 0.3 |
| EPS, diluted $ | −0.81 | −0.48 | −1.47 | −1.40 | −1.43 | −1.13 | −0.51 | −0.01 |
| Dividend / sh $ | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · |
| ROE % | −28.5 | −15.4 | −51.9 | −59.1 | −59.2 | −71.1 | −67.1 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 30 reconciliationsAUDITED
Reconciled in 8 of 19 fiscal years. 59 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inoutside the United States — SEC code E9
Fiscal year endsDecember 31
Data on record since2018